Mithridion Raises Series B Round
Mithridion Inc., a Madison, Wis.-based drug startup focused on CNS disorders like Alzheimer's disease, has raised $2.9 million in Series B funding. Venture Investors led the round, and was joined by Rocket Ventures, The State of Wisconsin Investment Board and Wisconsin Investment Partners. Mithridion has now raised $7.4 million in total VC funding.
12 January 2009•3 mins read
